California OKs stem cell measure

State will spend $3 billion on new institute; Bush wins presidency

Written byIvan Oransky
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

By a comfortable margin, Californians passed a $3 billion measure yesterday (November 2) that will create an Institute for Regenerative Medicine based on embryonic stem cell research. The measure, known as Proposition 71, won 59% of the vote, or 5,576,831 votes, with 99% of precincts reporting by this morning, according to CNN.com.

Despite California's budget deficit, there had been little organized opposition to the California stem cell initiative. The measure prohibits funding of human reproductive cloning efforts and would dole out the funds over 10 years. The $300 million per year would dwarf current federal funding for embryonic stem cell research, which is about $25 million per year.

As had been expected, a majority (55%) of Californians also voted for Sen. John Kerry, compared with 44% for President George Bush, but this morning, Kerry called Bush to concede the national election. The election had been considered too close to call ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform